Efficacy of Over-glasses Patch Treatment for Amblyopia in Children : OPTA Study (OPTA)
Efficacy of Over-glasses Patch Treatment for Amblyopia in Children :OPTA Study, A Prospective Randomized Clinical Trial
研究概览
详细说明
研究类型
注册 (实际的)
阶段
- 不适用
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- moderate amblyopia (logMAR visual acuity in the amblyopic eye 0.3 to 0.7 inclusive)
- logMAR visual acuity in the sound eye of 0.1 or better
- intereye acuity difference of larger or equal to 0.3 of logMAR visual acuity
- the presence of or a history of an amblyogenic factor meeting study-specified criteria for strabismus and/or anisometropia.
Exclusion Criteria:
- presence of an ocular cause for low vision
- myopia greater than -6.0 diopters (D) spherical equivalent in either eye
- prior intraocular or refractive surgery
- treatment for amblyopia (other than spectacle correction) within the 6 months prior to the enrollment
- Down syndrome
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Conventional patch
The patients were prescribed 2 hours of patching per day for the sound eye and the spectacles were to be worn full-time. Conventional patch is occlusion treatment sticker (Opticlude Eye Patch, 3M, Maplewood, MN, USA) with an adhesive material attached to the skin and serves to cover the eyes. |
Conventional patch (Opticlude Eye Patch, 3M, Maplewood, MN, USA) is applied to the patients.
They were prescribed 2 hours of patching per day for the sound eye.
|
|
实验性的:over-glasses patch
the patients were prescribed 2 hours of patching per day for the sound eye and the spectacles were to be worn full-time. Over-glasses patch (Tomato Eye Patch, Tomato Inc., Busan, South Korea) is made of fabric and covers the glasses, hence serves to cover the eyes. |
Over-glasses patch (Tomato Eye Patch, Tomato Inc., Busan, South Korea) is applied to the patients.
They were prescribed 2 hours of patching per day for the sound eye.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Changes in visual acuity (logMAR)
大体时间:17 weeks
|
changes in best- corrected visual acuity between before treatment and after 17 weeks. Visual acuity is assessed using the Snellen chart. logMAR visual acuity ranges 0.0 to 3.0. logMAR visual acuity of 0.0 corresponds to 20/20. Lower scores represents better functioning. |
17 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
amblyopia treatment index
大体时间:17 weeks
|
A modified version of ATI was provided to the parent(s) of all the enrolled minor patients as part of their follow-up visit with their child.
The test consisted of 20 items, translated to Korean by one English language specialist and three ophthalmologists.
The score from each question contributed to a sub-scale of the adverse effect (question numbers 2, 3, 4, 7, 8, 9, 13, and 16), compliance (question numbers 1, 5, 6a, 10 and 12), and social stigma (question numbers 11, 14 and 18).
The questionnaires were scored on a 5-point Likert scale system, and the parent-provided questionnaire used a strength of agreement scale with responses of "strongly agree" (5), "agree" (4), "neither agree nor disagree" (3), "disagree" (2), "strongly disagree" (1), and "not applicable."
In the test, the majority of items were negative statements, and therefore, a higher score indicated a higher negative impact or a higher burden.
Reverse scoring was applied to the few items that were positive statements.
|
17 weeks
|
|
the best corrected visual acuity
大体时间:17 weeks
|
best corrected visual acuity (logMAR) at 17 weeks Visual acuity is assessed using the Snellen chart.
logMAR visual acuity ranges 0.0 to 3.0.
logMAR visual acuity of 0.0 corresponds to 20/20.
Lower scores represents better functioning.
|
17 weeks
|
|
change of binocularity
大体时间:17 weeks
|
A binocularity index was determined with the use of the Worth 4 Dot test at near and the Titmus stereo test with a scale ranging from 0 to 4 with the following characteristics: 0, indicating complete suppression; 1, a moderate central suppression scotoma with peripheral fusion at near only indicated by fusion on the Worth 4 Dot test at near; 2, a small suppression scotoma and peripheral fusion indicated by fusion of the Titmus stereo fly; 3, moderate stereoacuity (100-400 arc seconds) on the stereo test animals (1 to 3 animals) and/or on the stereo test circles (1 to 5 circles); and 4, good stereoacuity (<80 arc seconds ) on the stereo test circles (6 to 9 circles).
|
17 weeks
|
合作者和调查者
调查人员
- 学习椅:Hee young Choi, MD, PhD、Pusan National University hospotal
出版物和有用的链接
一般刊物
- Scheiman MM, Hertle RW, Beck RW, Edwards AR, Birch E, Cotter SA, Crouch ER Jr, Cruz OA, Davitt BV, Donahue S, Holmes JM, Lyon DW, Repka MX, Sala NA, Silbert DI, Suh DW, Tamkins SM; Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005 Apr;123(4):437-47. doi: 10.1001/archopht.123.4.437.
- Flynn JT, Schiffman J, Feuer W, Corona A. The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc. 1998;96:431-50; discussion 450-3.
- Wallace MP, Stewart CE, Moseley MJ, Stephens DA, Fielder AR; Monitored Occlusion Treatment Amblyopia Study (MOTAS) Cooperatives; Randomized Occlusion Treatment Amblyopia Study (ROTAS) Cooperatives. Compliance with occlusion therapy for childhood amblyopia. Invest Ophthalmol Vis Sci. 2013 Sep 17;54(9):6158-66. doi: 10.1167/iovs.13-11861.
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.